Found: 31
Select item for more details and to access through your institution.
Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer.
- Published in:
- Journal of NeuroVirology, 2013, v. 19, n. 1, p. 89, doi. 10.1007/s13365-012-0145-7
- By:
- Publication type:
- Article
Molecular Pathology of Neuro-AIDS (CNS-HIV).
- Published in:
- International Journal of Molecular Sciences, 2009, v. 10, n. 3, p. 1045, doi. 10.3390/ijms10031045
- By:
- Publication type:
- Article
Neuroprotective effects of cerebrolysin in a Picks-like model of tauopathy
- Published in:
- 2012
- By:
- Publication type:
- Abstract
A Novel Triple Repeat Mutant Tau Transgenic Model That Mimics Aspects of Pick’s Disease and Fronto-Temporal Tauopathies.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0121570
- By:
- Publication type:
- Article
Differential Effects of UCHL1 Modulation on Alpha-Synuclein in PD-Like Models of Alpha-Synucleinopathy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034713
- By:
- Publication type:
- Article
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0019338
- By:
- Publication type:
- Article
Alterations in mGluR5 Expression and Signaling in Lewy Body Disease and in Transgenic Models of Alpha-Synucleinopathy -- Implications for Excitotoxicity.
- Published in:
- PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0014020
- By:
- Publication type:
- Article
Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy.
- Published in:
- PLoS ONE, 2010, v. 5, n. 2, p. 1, doi. 10.1371/journal.pone.0009313
- By:
- Publication type:
- Article
Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.
- Published in:
- Journal of Neuroscience Research, 2013, v. 91, n. 2, p. 167, doi. 10.1002/jnr.23142
- By:
- Publication type:
- Article
Increased BMP6 Levels in the Brains of Alzheimer's Disease Patients and APP Transgenic Mice Are Accompanied by Impaired Neurogenesis.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 37, p. 12252, doi. 10.1523/JNEUROSCI.1305-10.2010
- By:
- Publication type:
- Article
Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 18, p. 6236, doi. 10.1523/JNEUROSCI.0567-10.2010
- By:
- Publication type:
- Article
Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases.
- Published in:
- Journal of Neuroscience, 2009, v. 29, n. 43, p. 13578, doi. 10.1523/JNEUROSCI.4390-09.2009
- By:
- Publication type:
- Article
α-Synuclein Alters Notch-1 Expression and Neurogenesis in Mouse Embryonic Stem Cells and in the Hippocampus of Transgenic Mice.
- Published in:
- Journal of Neuroscience, 2008, v. 28, n. 16, p. 4250, doi. 10.1523/JNEUROSCI.0066-08.2008
- By:
- Publication type:
- Article
Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.
- Published in:
- BMC Neuroscience, 2014, v. 15, n. 1, p. 1, doi. 10.1186/1471-2202-15-90
- By:
- Publication type:
- Article
Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
- Published in:
- BMC Neuroscience, 2014, v. 15, n. 1, p. 90, doi. 10.1186/1471-2202-15-90
- By:
- Publication type:
- Article
Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir.
- Published in:
- BMC Neuroscience, 2008, v. 9, p. 1, doi. 10.1186/1471-2202-9-27
- By:
- Publication type:
- Article
ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 10, p. 1753, doi. 10.1038/mt.2014.129
- By:
- Publication type:
- Article
Lentivirus Mediated Delivery of Neurosin Promotes Clearance of Wild-type α-Synuclein and Reduces the Pathology in an α-Synuclein Model of LBD.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 1, p. 31, doi. 10.1038/mt.2012.66
- By:
- Publication type:
- Article
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
- Published in:
- Brain: A Journal of Neurology, 2014, v. 137, n. 5, p. 1496, doi. 10.1093/brain/awu057
- By:
- Publication type:
- Article
Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.
- Published in:
- Acta Neuropathologica, 2009, v. 117, n. 6, p. 699, doi. 10.1007/s00401-009-0505-4
- By:
- Publication type:
- Article
α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 6, p. 1100, doi. 10.1093/hmg/ddv633
- By:
- Publication type:
- Article
Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context.
- Published in:
- Human Molecular Genetics, 2012, v. 21, n. 11, p. 2432, doi. 10.1093/hmg/dds058
- By:
- Publication type:
- Article
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.
- Published in:
- Acta Neuropathologica, 2014, v. 127, n. 6, p. 861, doi. 10.1007/s00401-014-1256-4
- By:
- Publication type:
- Article
Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 24, p. 5757, doi. 10.1111/bph.12875
- By:
- Publication type:
- Article
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
- Published in:
- Molecular Neurodegeneration, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13024-015-0008-9
- By:
- Publication type:
- Article
Hippocampal neuronal cells that accumulate α- synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5 - implications for dementia with Lewy bodies.
- Published in:
- Molecular Neurodegeneration, 2014, v. 9, n. 1, p. 3, doi. 10.1186/1750-1326-9-18
- By:
- Publication type:
- Article
Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson's disease.
- Published in:
- Molecular Neurodegeneration, 2012, v. 7, n. 1, p. 49, doi. 10.1186/1750-1326-7-49
- By:
- Publication type:
- Article
Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson’s disease by disturbing calcium flux.
- Published in:
- Journal of Neurochemistry, 2009, v. 108, n. 6, p. 1561, doi. 10.1111/j.1471-4159.2009.05932.x
- By:
- Publication type:
- Article
Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models.
- Published in:
- Journal of Neuroscience, 2014, v. 34, n. 28, p. 9441, doi. 10.1523/JNEUROSCI.5314-13.2014
- By:
- Publication type:
- Article
In Vivo Alterations in Calcium Buffering Capacity in Transgenic Mouse Model of Synucleinopathy.
- Published in:
- Journal of Neuroscience, 2012, v. 32, n. 29, p. 9992, doi. 10.1523/JNEUROSCI.1270-12.2012
- By:
- Publication type:
- Article